<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/961756BF-E31F-4A13-836F-0A09BA02385C"><gtr:id>961756BF-E31F-4A13-836F-0A09BA02385C</gtr:id><gtr:name>University of Exeter</gtr:name><gtr:address><gtr:line1>University of Exeter</gtr:line1><gtr:line2>Clydesdale House</gtr:line2><gtr:line3>Clydesdale Road</gtr:line3><gtr:line4>Exeter</gtr:line4><gtr:postCode>EX4 4QX</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:department>Human Genetics</gtr:department><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/961756BF-E31F-4A13-836F-0A09BA02385C"><gtr:id>961756BF-E31F-4A13-836F-0A09BA02385C</gtr:id><gtr:name>University of Exeter</gtr:name><gtr:address><gtr:line1>University of Exeter</gtr:line1><gtr:line2>Clydesdale House</gtr:line2><gtr:line3>Clydesdale Road</gtr:line3><gtr:line4>Exeter</gtr:line4><gtr:postCode>EX4 4QX</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/BAB9694F-2AAB-40FB-B7A5-ED11FD6CE9FF"><gtr:id>BAB9694F-2AAB-40FB-B7A5-ED11FD6CE9FF</gtr:id><gtr:firstName>Jay</gtr:firstName><gtr:otherNames>E</gtr:otherNames><gtr:surname>Self</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0501759"><gtr:id>161DC268-E7DC-42B5-81DE-AA6C18B92FD8</gtr:id><gtr:title>Fine mapping and positional cloning of an X linked congenital nystagmus gene</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0501759</gtr:grantReference><gtr:abstractText>Congenital Idiopathic Nystagmus (CIN) causes rapid, involuntary, eye movements. It causes a significant visual problem and affects approximately 1 in 350 children. However, despite years of study, and the identification of one causative gene, the its pathogenesis is unknow. We have collected a large number of DNA samples and clinical details from patients with various forms of nystagmus which provides more chance than ever before of locating new genes for nystagmus and discovering how these genes function in health and can malfunction to cause nystagmus. Assesing the contribution of these genes to certain forms of nystagmus will instantly help some CIN children by allowing a simple genetic test and thus avoiding numerous invasive investigations. Furthermore, molecular biological techniques are being used to understand how the defective genes lead to uncontrolled eye movements. This knowledge will provide the first glimpses of the process underlying nystagmus but also may have relevance to many other ophthalmic and neurological diseases. It is hoped that this information will then lead to the design of novel therapies for these conditions.</gtr:abstractText><gtr:technicalSummary>Aims: to identify and characterise the first gene responsible for congenital idiopathic Nystagmus (CIN). 

CIN causes loss of vision and affects up to 1 in every 350 children. The cause is unknown and no treatments are commonly available. Autosomal dominant, recessive and X linked forms have been described although no genes have been identified to date. Two independent X linked loci have been reported. 

Objectives: To fine map and positionally clone an X linked CIN gene and to investigate it?s cell biology and function.

Design and methodology: 7 pedigrees with X linked CIN have been ascertained. The largest family (pedigree 1) has 4 living generations with 11 affected members and 25 informative meioses which gives a maximum lod score of 7.5 . 74 DNA samples have been collected from pedigree 1 (including 9 affected and 10 obligate female carriers). This now allows definitive linkage to be undertaken in this family. A further stock of 42 DNA samples from other x linked and sporadic CIN cases have also been collected. 24 patients from pedigree 1 have had detailed clinical phenotyping. This has included nystagmology and clinical examination. 4 patients have also had ERG and VEP recordings (excluding other diseases). Sequencing of the CDR1 gene in two members of pedigree 1 has excluded this gene as the cause of CIN in pedigree 1. Linkage analysis will now be performed using an ABI fluorescent microsatellite marker set. As appropriate, fine linkage mapping will be undertaken to further narrow the critical gene interval. Guided by the linkage interval identified, candidate genes will be identified and prioritized on the basis of their physical position, predicted function and mRNA expression. Once the disease gene is identified a second independent mutation will be confirmed in additional families. The disease gene?s function will then be determined by studying its tissue and cellular expression and co-localization with known proteins. This will be achieved witcombination of mRNA expression, tissue in-situ hybridization and immunohistochemistry experiments. 

Scientific and medical opportunities:
This research has a high chance of identifying the first disease gene and molecular mechanisms underlying CIN. Such knowledge should ultimately lead to the development of novel therapies which to date, despite multidisciplinary study, have eluded researchers in this field. It will also provide insight into central neuromuscular control of striated muscle. This could have relevance for a wide range of poorly understood neurological disease.</gtr:technicalSummary><gtr:fund><gtr:end>2008-04-21</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>181969</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Exeter</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Professor crosby in Exeter</gtr:description><gtr:id>DB294CE2-F1DF-4456-A79B-91DCE5F86F01</gtr:id><gtr:impact>Mustafa Y. Ahmed MB ChB1,8, Aisha Al-Khayat MSc, PhD2,8, Barry A. Chioza PhD1,8, J. Pedro Fernandez-Murray PhD3, Jay E Self BM FRCOphth PhD4, Gaurav Harlalka1, Amaury Cazenave-Gassiot PhD5, Markus R. Wenk PhD6, Fatema Al-Salemi MSc2, Michael A. Patton MB ChB, MA, MSc, DCH, FRCP, FRCPCH1,2, David L. Silver PhD7 Emma Louise Baple MBBS, MRCPCH, PhD1,4,*, Christopher R. McMaster PhD3, Andrew H. Crosby PhD1, * Impaired Kennedy pathway phospholipid biosynthesis due to EPT1 mutation underlies neurodevelopmental delay and spastic paraplegia. Accepted. BRAIN. November 2016.


This collaboration is multidisciplinary and includes the following disciplines: Clinical Ophthalmology, Molecular genetics, Genetic Epidemiology, Protein Biology and Neurology.</gtr:impact><gtr:outcomeId>58b7e2fc33d170.90707690-1</gtr:outcomeId><gtr:partnerContribution>They have established links with these populations and work on the ground to collect data and DNA. We work together on study design and gene discovery.</gtr:partnerContribution><gtr:piContribution>We collaborate on a joint project looking at rural Pakistani and Amish populations using autozygosity mapping to identify new genes and establish local genetic testing workflows. We do wet lab genetics work for this collaboration in addition to me co-supervising a PhD student.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Nystagmus network websites</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>8DDAE42A-9A78-4BFC-85AE-D8ED7E513C29</gtr:id><gtr:impact>Two charity websites now feature details of my work.

This has helped to raise awareness of the current research in this area and has lead to recruitment of many patients.</gtr:impact><gtr:outcomeId>B2CDE98BF14</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>RNIB openday</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:id>4726780B-769C-4887-BEB0-B270ABBD3D80</gtr:id><gtr:impact>An open day organised at the RNIB in London where the public were invited to come and quizz a panel of medical and research experts.

Some media coverage</gtr:impact><gtr:outcomeId>0384407D95D</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Local Schools</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>A26D2F4C-33C6-4402-9185-C5C66D6FBF87</gtr:id><gtr:impact>Many visits to local schools to highlight the work of our laboratory and promote our local eye research charity. Additional lectures to local commuinity groups and others.

Fundraising activities and general awareness of my work and projects have reased.</gtr:impact><gtr:outcomeId>1E3A0065D57</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Nystagmus Network international symposium</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>198F4613-9CCA-4D47-AB88-5394FDC91350</gtr:id><gtr:impact>These were invited only international symposia for nystagmus researchers. I am helping to organise the meeting and running a section of the meeting.

A book is being published about the meeting and its findings.</gtr:impact><gtr:outcomeId>50A2A9A5ED6</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>A website detailing my work and significant achievements</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>3A3DE2B2-1EA8-49C1-BEEA-EBBEDDC6C6F8</gtr:id><gtr:impact>This website includes our research groups work.

Interest has lead to recruitment of patients and charity fundraising.</gtr:impact><gtr:outcomeId>4DA25D9D0BE</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Newspaper feature</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>84E9ADDD-36BC-47CB-8A63-A0497118F8D5</gtr:id><gtr:impact>Our work was highlighted in a local newspaper with a full double paged feature which included a large section on this work.

Donations increased as did general interest in the work and recruitement of patients.</gtr:impact><gtr:outcomeId>3A6B5A68632</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Advisor to the Nystagmus Network</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>55A94F6D-E2EA-4C1B-833C-040FAF9C47AD</gtr:id><gtr:impact>I have helped to organise and steer the only international invited only symposia on Nystagmus research in 2005 and 2009. This involed the recruitment of experts from around the world and the joining of disparate research groups with a common interest.</gtr:impact><gtr:outcomeId>35A699E10C4</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Nystagmus Guidelines</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:guidelineTitle>Royal College of Ophthalmologists guidelines on Nystagmus</gtr:guidelineTitle><gtr:id>AFE6C164-1EB3-481D-9352-A32F3C89BA38</gtr:id><gtr:impact>We have helped to guide the necessary workup of children with nystagmus and contributed to the genetic testing available for children with this dibilitating disorder.</gtr:impact><gtr:outcomeId>AF5663525E8</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>EB5CA335-696C-4BA6-9C50-F31A15368C28</gtr:id><gtr:title>Frmd7 expression in developing mouse brain.</gtr:title><gtr:parentPublicationTitle>Eye (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2eb240a61efb453289ad562ef16a39f"><gtr:id>f2eb240a61efb453289ad562ef16a39f</gtr:id><gtr:otherNames>Self J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0950-222X</gtr:issn><gtr:outcomeId>23E3AA74F90</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4CFACAF-2667-40FF-BE44-0B1095E1C397</gtr:id><gtr:title>A review of the molecular genetics of congenital Idiopathic Nystagmus (CIN).</gtr:title><gtr:parentPublicationTitle>Ophthalmic genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2eb240a61efb453289ad562ef16a39f"><gtr:id>f2eb240a61efb453289ad562ef16a39f</gtr:id><gtr:otherNames>Self J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1381-6810</gtr:issn><gtr:outcomeId>5a79754682fbd4.92201285</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C011BFA2-4420-471D-AB1D-CB4D8B10DC36</gtr:id><gtr:title>Is This Actually CIN?</gtr:title><gtr:parentPublicationTitle>Pediatric neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d208251eaaf003bfdd892c0df436b84"><gtr:id>9d208251eaaf003bfdd892c0df436b84</gtr:id><gtr:otherNames>Self JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0887-8994</gtr:issn><gtr:outcomeId>56d979516a7368.14788955</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25E2605D-5573-48BA-A2D5-0D28B5F6F279</gtr:id><gtr:title>Infantile nystagmus and late onset ataxia associated with a CACNA1A mutation in the intracellular loop between s4 and s5 of domain 3.</gtr:title><gtr:parentPublicationTitle>Eye (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2eb240a61efb453289ad562ef16a39f"><gtr:id>f2eb240a61efb453289ad562ef16a39f</gtr:id><gtr:otherNames>Self J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0950-222X</gtr:issn><gtr:outcomeId>5a7975465827c6.43578561</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30241BA7-7C27-4523-B951-7B289B80F4B9</gtr:id><gtr:title>The molecular genetics of congenital idiopathic nystagmus.</gtr:title><gtr:parentPublicationTitle>Seminars in ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2eb240a61efb453289ad562ef16a39f"><gtr:id>f2eb240a61efb453289ad562ef16a39f</gtr:id><gtr:otherNames>Self J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0882-0538</gtr:issn><gtr:outcomeId>45F307627EC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7FB96E48-FCE8-43A4-ACBF-75496891369A</gtr:id><gtr:title>Allelic variation of the FRMD7 gene in congenital idiopathic nystagmus.</gtr:title><gtr:parentPublicationTitle>Archives of ophthalmology (Chicago, Ill. : 1960)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d208251eaaf003bfdd892c0df436b84"><gtr:id>9d208251eaaf003bfdd892c0df436b84</gtr:id><gtr:otherNames>Self JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0003-9950</gtr:issn><gtr:outcomeId>4E948BE31A6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E92A090C-DA3F-479D-9762-CD7C938AB054</gtr:id><gtr:title>Fine mapping of the X-linked recessive congenital idiopathic nystagmus locus at Xq24-q26.3.</gtr:title><gtr:parentPublicationTitle>Molecular vision</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d208251eaaf003bfdd892c0df436b84"><gtr:id>9d208251eaaf003bfdd892c0df436b84</gtr:id><gtr:otherNames>Self JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1090-0535</gtr:issn><gtr:outcomeId>5a797546c50db9.83350239</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>459F395F-34B7-4B7C-A79B-726397C44CC8</gtr:id><gtr:title>Identification of a functionally significant tri-allelic genotype in the Tyrosinase gene (TYR) causing hypomorphic oculocutaneous albinism (OCA1B).</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b6f1fb42bcad958e0641c99f895d52b"><gtr:id>5b6f1fb42bcad958e0641c99f895d52b</gtr:id><gtr:otherNames>Norman CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a7975458a7b50.04634610</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0501759</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>A9061818-9B1E-495A-9617-7C77200827C2</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Eye</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>